Home » Market News » DirectorsTalk Highlights » Lupus Has Made It Difficult to Work Full Time
Immupharma Plc

Lupus Has Made It Difficult to Work Full Time

Having lupus is hard enough, but when a full-time job is added in, it is almost unbearable. Sleep is always an issue. It seems like we never get enough. And then taking a shower uses up what little energy we have left. We are exhausted by the time we actually make it to work.

I am so lucky that I can work from home most days. As a real estate broker, I used to tour four or five houses in a day. I dreaded the ones with multiple floors, as they were the hardest for me. By the end of the day, I could barely walk, much less climb stairs.

My husband is also a broker, so we formed a team. Working together means that he can do the legwork on my bad days. I’m a stickler for details, so I do most of the paperwork, and that can be done anywhere.

ImmuPharma PLC (LON:IMM) is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by High unmet medical need,Low marketing costs and Relatively low development costs

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.